Waters Corporation ($WAT) Stock Forecast: Up 5.2% Today

What is Waters Corporation?

Waters Corp. (NYSE: WAT) is a global provider of analytical instruments, software, and services for laboratory and research applications, catering to various industries. Today, the stock had a strong bullish movement in the market.

Why is Waters Corporation going up?

WAT stock is up 5.2% on Jan 6, 2026 15:21

• Received an Outperform rating with projections of significant EPS growth by 2030 due to synergies from the BD Biosciences and Diagnostics Solutions acquisition.
• Strong Q3 2025 financial results surpassed analyst expectations, leading to multiple upgrades and price target increases.
• Estimated intrinsic value suggests the current share price is trading at similar levels to fair value, indicating a balanced valuation.
• The combination of favorable analyst ratings, strategic acquisitions, and solid financial performance likely contributed to the bullish movement in the stock today.

WAT Price Chart

WAT Technical Analysis

WAT News

The Truth About Agilent Technologies Inc: Quiet Lab Stock That Might Be Your Next Power Play

Agilent Technologies Inc (A) is presented as a quiet yet powerful player in the lab technology sector, supporting pharma, biotech, and semiconductor industries. The article suggests that while it lacks the viral "hype" of AI or meme stocks, its "picks-and-shovels" business model, steady growth, and integral role in scientific research make it a compelling long-term investment. It is compared to competitors like Thermo Fisher Scientific, highlighting Agilent's focus on precision instruments and analytics.

https://www.ad-hoc-news.de/boerse/news/ueberblick/the-truth-about-agilent-technologies-inc-quiet-lab-stock-that-might-be/68462354

William Blair inicia cobertura da Waters com recomendação de Outperform

William Blair iniciou a cobertura da Waters Corp. (NYSE:WAT) com uma recomendação de Outperform, projetando que a aquisição da BD Biosciences and Diagnostics Solutions impulsionará o lucro por ação para quase US$ 22 até 2030. Esta análise coincide com a Waters reportando resultados financeiros do terceiro trimestre de 2025 acima do esperado e recebendo classificações positivas de outras firmas de análise como Wolfe Research e Morgan Stanley.

https://br.investing.com/news/analyst-ratings/william-blair-inicia-cobertura-da-waters-com-recomendacao-de-outperform-93CH-1789304

William Blair initiates Waters stock with Outperform rating, sees BD acquisition synergies

William Blair initiated coverage on Waters Corp. (NYSE:WAT) with an Outperform rating, citing better-than-expected fit and synergy potential from the BD Biosciences and Diagnostics Solutions portfolio acquisition. The firm projects mid-teens EPS compound annual growth and nearly $22 EPS by 2030 due to the transaction's benefits. This positive outlook follows strong Q3 2025 results for Waters, which exceeded analyst expectations and led to several analyst upgrades and price target increases.

https://ng.investing.com/news/analyst-ratings/william-blair-initiates-waters-stock-with-outperform-rating-sees-bd-acquisition-synergies-93CH-2273353

Estimating The Intrinsic Value Of Waters Corporation (NYSE:WAT)

This article estimates the intrinsic value of Waters Corporation (NYSE: WAT) using a 2-stage Discounted Cash Flow (DCF) model. The analysis suggests a fair value of US$362 for Waters, indicating its current share price of US$382 is trading at similar levels. The valuation considers future cash flows, a terminal value calculation, and a discount rate of 7.9%.

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-wat/waters/news/estimating-the-intrinsic-value-of-waters-corporation-nysewat-2

Waters (WAT) Stock Price, News & Analysis

This article provides a comprehensive overview of Waters (WAT) stock, including its current price, news, and various analytical data. It covers analyst ratings, earnings forecasts, short interest, dividend information, news sentiment, and company ownership. Waters Corporation is highlighted as a global provider of analytical instruments, software, and services for laboratory and research applications, serving diverse end markets.

https://www.marketbeat.com/stocks/NYSE/WAT/

Trending Today

Natural Gas ($GAS) Commodity Forecast: Up 29.2% Today

Ethereum ($ETH) Crypto Forecast: Down 5.1% Today

The Sandbox ($SAND) Crypto Forecast: Up 5.1% Today

TRON ($TRX) Crypto Forecast: Down 5.0% Today

Dash ($DASH) Crypto Forecast: Down 5.7% Today

Monero ($XMR) Crypto Forecast: Down 18.9% Today

Dogecoin ($DOGE) Crypto Forecast: Down 5.0% Today

FuelCell Energy ($FCEL) Stock Forecast: Up 5.2% Today

Enphase Energy Inc. ($ENPH) Stock Forecast: Down 5.8% Today

Illumina Inc. ($ILMN) Stock Forecast: Up 5.2% Today

Waters Corporation Price History

01.10.2024 - WAT Stock was up 16.7%

• Waters Corporation (WAT) had a strong bullish movement today.
• The stock beat Q3 earnings and revenue estimates by 9.33% and 3.65% respectively, indicating strong financial performance.
• Expectations of beating earnings estimates further fueled investor optimism, driving the stock higher.
• The positive results and outlook suggest that Waters Corporation is on a solid growth trajectory, attracting more investors to the stock.

06.00.2026 - WAT Stock was up 5.2%

• Received an Outperform rating with projections of significant EPS growth by 2030 due to synergies from the BD Biosciences and Diagnostics Solutions acquisition.
• Strong Q3 2025 financial results surpassed analyst expectations, leading to multiple upgrades and price target increases.
• Estimated intrinsic value suggests the current share price is trading at similar levels to fair value, indicating a balanced valuation.
• The combination of favorable analyst ratings, strategic acquisitions, and solid financial performance likely contributed to the bullish movement in the stock today.

05.00.2026 - WAT Stock was up 1.7%

• An analyst initiated coverage on Waters Corp with an Outperform rating, referencing synergies from the BD acquisition as a primary growth driver, leading to a positive market sentiment.
• The alignment of Waters' intrinsic value with its current share price suggests investors view the stock as fairly valued, contributing to the bullish momentum.
• Despite a challenging year for capital spending, Waters Corp's strategic shift towards recurring revenue streams and focus on high-value biopharma and QA/QC workflows have instilled confidence among analysts, supporting the bullish trend.
• The company's disciplined approach to rebuilding, integration of core hardware with software and data analytics, and emphasis on becoming a resilient platform provider have positioned it well for potential future growth, further boosting investor optimism and driving the bullish market movement.

15.06.2025 - WAT Stock was down 5.8%

• The bearish movement in Waters Corporation's stock today can be attributed to the market's reaction to the collaboration news with Becton Dickinson.
• Investors might be concerned about the long-term implications of the $17.5B deal and the ambitious revenue targets set for 2030, which could lead to uncertainty and selling pressure on Waters' stock.
• The market might be interpreting the partnership as a potential risk factor for Waters' standalone growth prospects, leading to a pessimistic sentiment among investors and triggering the bearish movement in the stock price.
• Investors may be waiting for more clarity on how the collaboration will impact Waters' financials and strategic direction before reassessing the stock's valuation and growth potential.

04.10.2025 - WAT Stock was up 6.7%

• Waters Corporation (WAT) exceeded Q3 earnings and revenue estimates, indicating strong financial performance.
• The positive surprises in earnings and revenue suggest that the company's products and services are in high demand.
• Investors are likely optimistic about Waters' future prospects, leading to a bullish movement in the stock price.
• The strong quarterly results may attract more investors and analysts' attention, further boosting the stock's performance in the near term.

14.06.2025 - WAT Stock was down 4.6%

• The decline in Waters' stock value could be linked to Becton Dickinson's optimistic projections for its diagnostics business, potentially overshadowing Waters' own performance forecasts.
• Investor apprehension regarding the competitive dynamics within the diagnostics industry may have intensified following the announcement of the merged company's ambitious revenue and EBITDA goals for 2030.
• The market's response might reflect concerns over the perceived competitive challenge posed by Becton Dickinson's growth strategies, prompting a selloff of Waters' shares as market participants reassess their sectoral investments.
• This development likely influenced investor sentiment towards viewing Becton Dickinson as a more appealing healthcare industry investment opportunity, thereby exerting a negative impact on Waters' stock value.

23.03.2024 - WAT Stock was up 5.0%

• The recent unveiling of the GTxResolve Premier SEC Columns by Waters Corporation, aimed at boosting sensitivity and resolution in gene-based therapeutics development, has captured investor interest.
• The enhanced effectiveness and workflow provided by the new columns are viewed as a notable progression in the industry, leading to a rise in WAT's stock value.
• Investors are reacting positively to Waters Corporation's emphasis on innovation and its potential to be a significant player in the rapidly expanding cell & gene-based therapeutics market.

10.04.2024 - WAT Stock was up 5.4%

• The bullish movement in WAT stock is a result of the company surpassing the estimated Q1 earnings per share, with adjusted earnings of $2.21.
• Despite a decrease in quarterly revenues, the improvement in gross margin and adjusted operating margin likely boosted investor confidence.
• The introduction of the ACQUITY QDa II Mass Detector, providing enhanced chemical analysis at a reduced cost, may have contributed to the positive market sentiment.
• The decline in sales in China was potentially overlooked due to the overall strong performance and growth outlook of Waters Corporation, driving the bullish market movement.

30.04.2024 - WAT Stock was down 5.8%

• Despite insider buying activity by Director Richard Fearon, indicating confidence in Waters Corp, the stock still experienced a bearish movement.
• The broader market downturn might have overshadowed the positive sentiment from insider purchases.
• Investors may have been influenced more by the overall market sentiment rather than individual insider transactions.
• It's possible that external factors or market conditions impacted Waters Corp more significantly than insider buying activity today.

11.06.2024 - WAT Stock was up 5.8%

• The announcement of $WAT Coin, a new cryptocurrency honoring Matt Furie's artistic legacy, likely generated excitement and interest in the market.
• The connection to the creator of PEPE, a well-known internet meme, could have attracted a wave of speculative investors looking for the next trending token.
• The novelty and unique concept of a cryptocurrency inspired by a pet rat could have captured the attention of both crypto enthusiasts and art collectors, driving up demand for $WAT.
• The timing of the launch amidst the evolving landscape of cryptocurrencies might have contributed to the bullish movement as investors seek new opportunities in the market.

06.04.2025 - WAT Stock was down 5.0%

• Waters (WAT) beat earnings and revenue estimates for the first quarter of 2025 but experienced a strong bearish movement.
• The market's negative reaction may be related to concerns about future growth prospects or guidance from the company.
• Investors may have anticipated higher performance or guidance, resulting in a stock sell-off.
• Macroeconomic factors or challenges specific to the industry could be overshadowing the positive earnings results, causing the bearish movement in WAT's stock price.

01.07.2025 - WAT Stock was down 6.4%

• The bearish movement in WAT today could be due to profit-taking by investors after a period of strong growth.
• Despite the positive expectations for the upcoming earnings report, market sentiment may have shifted, leading to a sell-off of WAT shares.
• It's possible that some investors are cautious about the company's future outlook or there may be broader market concerns impacting WAT's stock price.
• Overall, the bearish movement in WAT today may be a short-term correction rather than a reflection of the company's long-term prospects.